Financials
- Market Capitalization 2.2 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-6.2
売上高対価格比率
0.99
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1923 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.60 USD | -1.58% | -0.31% | -2.51% | -36.59% | 2.26 B USD | ||
| 1924 | MESO Mesoblast Limited - American Depositary Shares | 17.44 USD | -4.07% | +3.81% | +20.28% | +33.64% | 2.26 B USD | ||
| 1948 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +10.07% | +36.55% | 2.17 B USD | ||
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +6.13% | +129.58% | 2.13 B USD |